CIK 0000014272
- Large accelerated filer
BRISTOL MYERS SQUIBB CO
Sign in to watch- Ticker
- BMY
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 220790350
- Phone
- +1 609-252-4621
- Business address
- ROUTE 206 AND PROVINCE LINE ROAD, PRINCETON, NJ, 08543
Securities
- BMY Bristol-Myers Squibb Company Common Stock NYSE
- CELG-RI Rights NYSE
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $677,826
- in 3 filings
Net −$677,826. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-03 | VESSEY RUPERT EVP & President, Research | Sale | −50,385 | $67.06 | $3.4M | 47,751 |
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Exercise or conversion | +7,423 | 68,796 | ||
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Other acquisition | +1,373 | 70,169 | ||
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Shares withheld for taxes | −4,500 | $65.71 | $296K | 65,669 |
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Exercise or conversion | +7,824 | 73,493 | ||
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Other acquisition | +1,284 | 74,777 | ||
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Shares withheld for taxes | −4,659 | $65.71 | $306K | 70,118 |
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Exercise or conversion | +7,147 | 77,265 | ||
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Other acquisition | +231 | 77,496 | ||
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Shares withheld for taxes | −3,774 | $65.71 | $248K | 73,722 |
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Exercise or conversion | +44,541 | 118,263 | ||
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Other acquisition | +5,438 | 123,701 | ||
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Shares withheld for taxes | −25,565 | $65.71 | $1.7M | 98,136 |
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Exercise or conversion · Market Share Units | −7,423 | 7,425 | ||
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Exercise or conversion · Market Share Units | −7,824 | 15,651 | ||
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Exercise or conversion · Market Share Units | −7,147 | 21,442 | ||
| 2023-03-10 | VESSEY RUPERT EVP & President, Research | Exercise or conversion · Performance Shares | −44,541 | 0 | ||
| 2022-12-02 | VESSEY RUPERT EVP, Research & Early Dev. | Exercise or conversion | +8,792 | 65,871 | ||
| 2022-12-02 | VESSEY RUPERT EVP, Research & Early Dev. | Shares withheld for taxes | −4,498 | $81.13 | $365K | 61,373 |
| 2022-12-02 | VESSEY RUPERT EVP, Research & Early Dev. | Exercise or conversion · Restricted Stock Units | −8,792 | 8,792 |
Page 1 of 7 · 133 trades